PharmaResources (Shanghai) Co., Ltd

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 28.75% vs -3.10% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 1,528.57% vs -105.38% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "161.20",
          "val2": "125.20",
          "chgp": "28.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.70",
          "val2": "17.30",
          "chgp": "-49.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "2.30",
          "chgp": "-13.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.90",
          "val2": "3.80",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.00",
          "val2": "-0.70",
          "chgp": "1,528.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "53.90%",
          "val2": "-33.80%",
          "chgp": "8.77%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.10% vs 2.37% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -54.52% vs -44.05% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "542.70",
          "val2": "488.50",
          "chgp": "11.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "69.20",
          "val2": "76.60",
          "chgp": "-9.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.50",
          "val2": "5.60",
          "chgp": "69.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.10",
          "val2": "5.60",
          "chgp": "-8.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17.10",
          "val2": "37.60",
          "chgp": "-54.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-15.50%",
          "val2": "57.60%",
          "chgp": "-7.31%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

161.20

125.20

28.75%

Operating Profit (PBDIT) excl Other Income

8.70

17.30

-49.71%

Interest

2.00

2.30

-13.04%

Exceptional Items

1.90

3.80

-50.00%

Consolidate Net Profit

10.00

-0.70

1,528.57%

Operating Profit Margin (Excl OI)

53.90%

-33.80%

8.77%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 28.75% vs -3.10% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 1,528.57% vs -105.38% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

542.70

488.50

11.10%

Operating Profit (PBDIT) excl Other Income

69.20

76.60

-9.66%

Interest

9.50

5.60

69.64%

Exceptional Items

5.10

5.60

-8.93%

Consolidate Net Profit

17.10

37.60

-54.52%

Operating Profit Margin (Excl OI)

-15.50%

57.60%

-7.31%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 11.10% vs 2.37% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -54.52% vs -44.05% in Dec 2023

All Annual Results